Eczemadoc is a digital health app that focuses on treating eczema by utilizing patient data to predict flare-ups and empower personalized care. Founded in 2020, the app aims to address the needs of the over 550 million individuals worldwide affected by this skin disorder. Eczemadoc's all-inclusive service leverages patient-provided data to identify the root causes of eczema, predict outbreaks, and offer personalized insights to prevent exacerbations.
The company's approach involves seamless journaling, integration of machine learning, and effective dermatologist consultations, allowing patients to take charge of their own personalized and preventive care. The last investment for Eczemadoc amounted to $175.00K in a Pre-Seed Round, which took place on 01 January 2022.
As of now, information regarding the specific location of Eczemadoc's headquarters and the investors involved in the last investment round is not available.
